FOXP2 regulates CNTNAP2 expression, and CNTNAP2 has been linked to complex neurological disorders, including language impairment, autism, dyslexia, schizophrenia, and depression, with Single Nucleotide Polymorphisms (SNPs) having been associated with specific language endophenotypes (see Rodenas-Cuadrado et al., 2014 for review). The gene discussed is CNTNAP2; the disease is depressive symptom measurement.